The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II trial of CAPOX with continuous versus intermittent use of oxaliplatin as an adjuvant chemotherapy after curative resection of stage II/III colon cancer (CCOG-1302 study).
 
Masanori Nakamura
No Relationships to Disclose
 
Goro Nakayama
No Relationships to Disclose
 
Kiyoshi Ishigure
No Relationships to Disclose
 
Naoki Mashita
No Relationships to Disclose
 
Hiroyuki Yokoyama
No Relationships to Disclose
 
Norifumi Hattori
No Relationships to Disclose
 
Keisuke Uehara
No Relationships to Disclose
 
Suguru Yamada
No Relationships to Disclose
 
Masahiko Koike
No Relationships to Disclose
 
Yasuhiro Kodera
Honoraria - Abbvie; Abbvie; Abbvie; Abbvie; Asahi Kasei; Asahi Kasei; Asahi Kasei; Asahi Kasei; Bristol-Myers Squibb Japan; Bristol-Myers Squibb Japan; Bristol-Myers Squibb Japan; Bristol-Myers Squibb Japan; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Covidien/Medtronic; Covidien/Medtronic; Covidien/Medtronic; Covidien/Medtronic; Dainippon Sumitomo Pharma; Dainippon Sumitomo Pharma; Dainippon Sumitomo Pharma; Dainippon Sumitomo Pharma; Hisamitsu Pharmaceutical; Hisamitsu Pharmaceutical; Hisamitsu Pharmaceutical; Hisamitsu Pharmaceutical; Intuitive Surgical; Intuitive Surgical; Intuitive Surgical; Intuitive Surgical; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Kaken Pharmaceutical; Kaken Pharmaceutical; Kaken Pharmaceutical; Kaken Pharmaceutical; Lilly; Lilly; Lilly; Lilly; MSD K.K; MSD K.K; MSD K.K; MSD K.K; Olympus; Olympus; Olympus; Olympus; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Otsuka; Otsuka; Otsuka; Otsuka; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Tsumura & Co.; Tsumura & Co.; Tsumura & Co.; Tsumura & Co.; Yakult Honsha; Yakult Honsha; Yakult Honsha; Yakult Honsha
Research Funding - abbott Japan (Inst); abbott Japan (Inst); abbott Japan (Inst); abbott Japan (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Bristol-Myers Squibb Japan (Inst); Bristol-Myers Squibb Japan (Inst); Bristol-Myers Squibb Japan (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Covidien (Inst); Covidien (Inst); Covidien (Inst); Covidien (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); Japan Blood Products Organization (Inst); Japan Blood Products Organization (Inst); Japan Blood Products Organization (Inst); Japan Blood Products Organization (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Maruho (Inst); Maruho (Inst); Maruho (Inst); Maruho (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); MSD (Inst); MSD (Inst); MSD (Inst); MSD (Inst); Nippon Kayaku (Inst); Nippon Kayaku (Inst); Nippon Kayaku (Inst); Nippon Kayaku (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst); Yakult Pharmaceutical (Inst); Yakult Pharmaceutical (Inst); Yakult Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)